Exploratory Pilot Study Evaluating the Biologic Activity of Guanabenz in Bone Metastasis
Phase of Trial: Phase I
Latest Information Update: 15 Feb 2018
At a glance
- Drugs Guanabenz (Primary)
- Indications Bone metastases
- Focus Pharmacodynamics
- 02 Mar 2017 Status changed from active, no longer recruiting to discontinued.
- 31 Aug 2016 Planned number of patients changed from 15 to 4.
- 31 Aug 2016 Planned primary completion date changed from 1 Apr 2017 to 1 Oct 2016.